# The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

> **NCT07278609** · — · RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 100 (estimated)

## Conditions studied

- Rheumatic Diseases
- Inflammatory Arthritis
- Systemic Lupus Erthematosus (SLE)
- Vasculitis
- Muskuloskeletal Diseases
- Systemic Autoimmune Diseases

## Interventions

- **BEHAVIORAL:** MedSafer deprescribing opportunity reports, EMPOWER brochures

## Key facts

- **NCT ID:** NCT07278609
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-29
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07278609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07278609, "The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07278609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*